Literature DB >> 30938004

Maternal and neonatal complications of fetal macrosomia: systematic review and meta-analysis.

J Beta1, N Khan1, A Khalil1, M Fiolna1, G Ramadan2, R Akolekar1,3.   

Abstract

OBJECTIVE: To determine accurate estimates of risks of maternal and neonatal complications in pregnancies with fetal macrosomia by performing a systematic review of the literature and meta-analysis.
METHODS: A search of MEDLINE, EMBASE, CINAHL and The Cochrane Library was performed to identify relevant studies reporting on maternal and/or neonatal complications in pregnancies with macrosomia having a birth weight (BW) > 4000 g and/or those with birth weight > 4500 g. Prospective and retrospective cohort and population-based studies that provided data regarding both cases and controls were included. Maternal outcomes assessed were emergency Cesarean section (CS), postpartum hemorrhage (PPH) and obstetric anal sphincter injury (OASIS). Neonatal outcomes assessed were shoulder dystocia, obstetric brachial plexus injury (OBPI) and birth fractures. Meta-analysis using a random-effects model was used to estimate weighted pooled estimates of summary statistics (odds ratio (OR) and 95% CI) for each complication, according to birth weight. Heterogeneity between studies was estimated using Cochran's Q, I2 statistic and funnel plots.
RESULTS: Seventeen studies reporting data on maternal and/or neonatal complications in pregnancy with macrosomia were included. In pregnancies with macrosomia having a BW > 4000 g, there was an increased risk of the maternal complications: emergency CS, PPH and OASIS, which had OR (95% CI) of 1.98 (1.80-2.18), 2.05 (1.90-2.22) and 1.91 (1.56-2.33), respectively. The corresponding values for pregnancies with BW > 4500 g were: 2.55 (2.33-2.78), 3.15 (2.14-4.63) and 2.56 (1.97-3.32). Similarly, in pregnancies with a BW > 4000 g, there was an increased risk of the neonatal complications: shoulder dystocia, OBPI and birth fractures, which had OR (95% CI) of 9.54 (6.76-13.46), 11.03 (7.06-17.23) and 6.43 (3.67-11.28), respectively. The corresponding values for pregnancies with a BW > 4500 g were: 15.64 (11.31-21.64), 19.87 (12.19-32.40) and 8.16 (2.75-24.23).
CONCLUSION: Macrosomia is associated with serious maternal and neonatal adverse outcomes. This study provides accurate estimates of these risks, which can be used for decisions on pregnancy management.
Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  brachial plexus injury; large-for-gestational age; macrosomia; obstetric sphincter injury; pregnancy complications; shoulder dystocia

Mesh:

Year:  2019        PMID: 30938004     DOI: 10.1002/uog.20279

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  36 in total

1.  Maternal prepregnancy BMI and size at birth: race/ethnicity-stratified, within-family associations in over 500,000 siblings.

Authors:  Janne Boone-Heinonen; Frances M Biel; Nicole E Marshall; Jonathan M Snowden
Journal:  Ann Epidemiol       Date:  2020-05-07       Impact factor: 3.797

2.  Interactions between Prepregnancy Overweight and Passive Smoking for Macrosomia and Large for Gestational Age in Chinese Pregnant Women.

Authors:  Dingyu Cui; Wen Yang; Ping Shao; Jing Li; Peng Wang; Junhong Leng; Shuo Wang; Enqing Liu; Juliana C N Chan; Zhijie Yu; Gang Hu; Xilin Yang
Journal:  Obes Facts       Date:  2021-08-20       Impact factor: 3.942

3.  Impact of fetal manipulation on maternal and neonatal severe morbidity during shoulder dystocia management.

Authors:  Bineta Diack; Fabrice Pierre; Bertrand Gachon
Journal:  Arch Gynecol Obstet       Date:  2022-09-23       Impact factor: 2.493

Review 4.  Prevalence of autism spectrum disorder diagnosis by birth weight, gestational age, and size for gestational age: a systematic review, meta-analysis, and meta-regression.

Authors:  Bao-Qiang Guo; Hong-Bin Li; De-Sheng Zhai; Li-Qiang Yang
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-09-06       Impact factor: 5.349

5.  Risk factors for caesarean delivery and fetal macrosomia among women with gestational diabetes in Nyeri County, Kenya: a cross-section study.

Authors:  Peter Kimani Njogu; Eliphas Gitonga Makunyi; Joseph Musau
Journal:  Pan Afr Med J       Date:  2022-04-20

6.  Association of Antidepressant Continuation in Pregnancy and Infant Birth Weight.

Authors:  Paige D Wartko; Noel S Weiss; Daniel A Enquobahrie; K C Gary Chan; Alyssa Stephenson-Famy; Beth A Mueller; Sascha Dublin
Journal:  J Clin Psychopharmacol       Date:  2021 Jul-Aug 01       Impact factor: 3.153

7.  Fetal macrosomia in home and birth center births in the United States: Maternal, fetal, and newborn outcomes.

Authors:  Sabrina Pillai; Melissa Cheyney; Courtney L Everson; Marit L Bovbjerg
Journal:  Birth       Date:  2020-10-15       Impact factor: 3.689

8.  The Association Between High Birth Weight and Long-Term Outcomes-Implications for Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis.

Authors:  Åsa Magnusson; Hannele Laivuori; Anne Loft; Nan B Oldereid; Anja Pinborg; Max Petzold; Liv Bente Romundstad; Viveca Söderström-Anttila; Christina Bergh
Journal:  Front Pediatr       Date:  2021-06-23       Impact factor: 3.418

9.  The Alteration of Carnitine Metabolism in Second Trimester in GDM and a Nomogram for Predicting Macrosomia.

Authors:  Man Sun; Baihui Zhao; Sainan He; Ruopeng Weng; Binqiao Wang; Yunping Ding; Xinwen Huang; Qiong Luo
Journal:  J Diabetes Res       Date:  2020-08-11       Impact factor: 4.011

10.  Separating parental and treatment contributions to perinatal health after fresh and frozen embryo transfer in assisted reproduction: A cohort study with within-sibship analysis.

Authors:  Kjersti Westvik-Johari; Liv Bente Romundstad; Deborah A Lawlor; Christina Bergh; Mika Gissler; Anna-Karina A Henningsen; Siri E Håberg; Ulla-Britt Wennerholm; Aila Tiitinen; Anja Pinborg; Signe Opdahl
Journal:  PLoS Med       Date:  2021-06-25       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.